Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that mainly affects older adults. Although the global burden of AD is increasing year by year, the causes of AD remain largely unknown. Numerous basic and clinical studies have shown that interleukin-17A (IL-17A) may play a signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xin-Zhu, Lai, Laijun, Ao, Qiang, Tian, Xiao-Hong, Zhang, Yan-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413786/
https://www.ncbi.nlm.nih.gov/pubmed/34429057
http://dx.doi.org/10.2174/1570159X19666210823110004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413786/
https://www.ncbi.nlm.nih.gov/pubmed/34429057
http://dx.doi.org/10.2174/1570159X19666210823110004

Ejemplares similares